Ultragenyx Pharmaceutical, Inc. (RARE)
22.61
+0.12
(+0.53%)
USD |
NASDAQ |
Jan 20, 15:10
Ultragenyx Pharmaceutical Total Assets (Quarterly): 1.190B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 823.61M |
| Johnson & Johnson | 192.82B |
| CorMedix, Inc. | 750.86M |
| Amicus Therapeutics, Inc. | 868.81M |
| Geron Corp. | 567.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.174B |
| Shareholders Equity (Quarterly) | 9.159M |
| Debt to Equity Ratio | 94.24 |
| Current Ratio | 1.892 |
| Net Debt Paydown Yield | 0.44% |